跳至主要内容
临床试验/NCT03986671
NCT03986671已完成不适用

A Pilot Study to Assess Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

Powell Mansfield Inc.2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Proof of Diagnostic Consistency

研究概览

简要总结

This is a pilot study to examine the diagnostic utility of a novel transmembrane surface sensor, and compare signals obtained with the transmembrane sensor to conventional needle EMG signals from healthy volunteers to those with documented neurologic pharyngeal muscle dysfunction (ALS and muscular dystrophy) and to those with severe OSA.

详细描述

Transmembrane electromyography (TM-EMG) may be a feasible and valid non-invasive EMG technique for detecting neuromuscular (NM) impairment. This study will assess whether, in healthy volunteers and participants with known obstructive sleep apnea (OSA) and other NM diseases involving the oropharynx, the same characteristic motor unit potentials obtained on conventional needle EMG (NEMG) can be obtained using a TM-EMG sensor. The purpose of this study is to demonstrate whether the TM-EMG sensor can provide the same diagnostic accuracy as the concentric needle electrode for the diagnosis of NM diseases. Having demonstrated diagnostic similarity of TM-EMG to NEMG, the secondary aim of this study is to confirm that NM disturbance of oropharyngeal striated muscles in participants with OSA can be elicited with the TM-EMG sensor.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-70
  • Must be able to pause use of anticoagulation, NSAID and multi-vitamins for appropriate period prior to study test.
  • Must be willing to stop any type of smoking or vaping 10 days prior to testing
  • A cohort of participants with documented neurological disorders involving upper airway striated muscles including ALS and muscular dystrophy with the presence of bulbar symptoms.
  • A cohort of participants diagnosed with moderate to severe OSA proven by an in-lab PSG, including the following criteria:
  • AHI > 25
  • Nadir SaO2 < 85%
  • not currently using CPAP
  • A cohort of healthy participants that meet the following criteria:
  • Normal craniofacial anatomy
  • BMI < 30

排除标准

  • Allergy to topical anesthetic
  • 4 or more alcoholic drinks on the same occasion on 5 or more days in the past month
  • Prior cancer, or radiation to the head or neck
  • Craniofacial anatomical disorders
  • Presence of any underlying medical, surgical or psychiatric disorder that would preclude participation as determined by the principal investigator

结局指标

主要结局

Proof of Diagnostic Consistency

时间窗: 1 hour

Proof of diagnostic consistency using both the TM-EMG sensor and NEMG in neuromuscular disorders of the oropharyngeal muscles. Significant Inter rater reliability between two blinded neuromuscular experts when using TM-EMG in the palatoglossal and genioglossus.

次要结局

未报告次要终点

研究者

发起方
Powell Mansfield Inc.
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验